CYTX Market Cap History



Below is a table of the CYTX market cap history going back to 5/24/2018:

Date CYTX Market Cap
5/24/201814.73M
7/31/20185.16M
10/31/20184.49M
1/31/20195.55M
4/30/20196.65M

Also see: CYTX Shares Outstanding History
and CYTX YTD Return
CYTX Historical Market Cap:
-58.73% CAGR
CYTX Historical Market Cap: +-58.73% CAGR

Mouse over chart for data details
5/24/20187/31/201810/31/20181/31/20194/30/2019
Cytori Therapeutics develops regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for various medical conditions. Co.'s drug candidates at its Cytori Nanomedicine platform include: ATI-0918, which is its primary drug candidate and a generic version of pegylated liposomal encapsulated doxorubicin; and ATI-1123, a chemical entity which is a nanoparticle-encapsulated form of docetaxel, also a workhorse chemotherapeutic drug used for various cancers. Co.'s product candidates at its Cytori Cell Therapy platform include Habeo™ Cell Therapy, which is its primary product candidate for the treatment of impaired hand function in patients with scleroderma. We show 5 historical shares outstanding datapoints in our CYTX shares outstanding history coverage, used to compute CYTX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CYTX market cap history over the course of time is important for investors interested in comparing CYTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CYTX versus a peer is one thing; comparing CYTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CYTX can fluctuate over the course of history. With this page we aim to empower investors researching CYTX by allowing them to research the CYTX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CYTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cytori Therapeutics (CYTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

DARE Market Cap History
DAWN Market Cap History
DBTX Market Cap History
DCGO Market Cap History
DCPH Market Cap History
DCTH Market Cap History
DEPO Market Cap History
DERM Market Cap History
DFFN Market Cap History
DGX Market Cap History
More Healthcare companies »

 

CYTX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.